These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 15491498)

  • 1. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.
    Yang B; Brown KK; Chen L; Carrick KM; Clifton LG; McNulty JA; Winegar DA; Strum JC; Stimpson SA; Pahel GL
    BMC Pharmacol; 2004 Oct; 4():23. PubMed ID: 15491498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats.
    Yang B; Lin P; Carrick KM; McNulty JA; Clifton LG; Winegar DA; Strum JC; Stimpson SA; Pahel GL
    Biochem Biophys Res Commun; 2005 Aug; 334(1):176-82. PubMed ID: 15993383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats.
    Yang B; Chen L; Qian Y; Triantafillou JA; McNulty JA; Carrick K; Clifton LG; Han B; Geske R; Strum J; Brown KK; Stimpson SA; Pahel G
    Biochem Biophys Res Commun; 2006 Mar; 341(1):209-17. PubMed ID: 16414018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.
    Golfman LS; Wilson CR; Sharma S; Burgmaier M; Young ME; Guthrie PH; Van Arsdall M; Adrogue JV; Brown KK; Taegtmeyer H
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E328-36. PubMed ID: 15797988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
    Qi Z; Xue J; Zhang Y; Wang H; Xie M
    Planta Med; 2011 Feb; 77(3):231-5. PubMed ID: 20717873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
    Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Pelzer T; Jazbutyte V; Arias-Loza PA; Segerer S; Lichtenwald M; Law MP; Schäfers M; Ertl G; Neyses L
    Biochem Biophys Res Commun; 2005 Apr; 329(2):726-32. PubMed ID: 15737646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats.
    Chen L; Yang B; McNulty JA; Clifton LG; Binz JG; Grimes AM; Strum JC; Harrington WW; Chen Z; Balon TW; Stimpson SA; Brown KK
    J Pharmacol Exp Ther; 2005 Feb; 312(2):718-25. PubMed ID: 15475592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
    Laurent D; Gounarides JS; Gao J; Boettcher BR
    Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
    Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
    Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitization with a peroxisome proliferator-activated receptor γ agonist prevents adrenocortical lipid infiltration and secretory changes induced by a high-sucrose diet.
    Martinez Calejman C; Di Gruccio JM; Mercau ME; Repetto EM; Astort F; Sanchez R; Pandolfi M; Berg G; Schreier L; Arias P; Cymeryng CB
    J Endocrinol; 2012 Sep; 214(3):267-76. PubMed ID: 22700193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.
    Li L; Yang G; Li Q; Tang Y; Li K
    Ann Nutr Metab; 2006; 50(6):499-505. PubMed ID: 17191023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin sensitizing effects of PPAR-γ agonist are associated to changes in adiponectin index and adiponectin receptors in Zucker fatty rats.
    Pita J; Panadero A; Soriano-Guillén L; Rodríguez E; Rovira A
    Regul Pept; 2012 Feb; 174(1-3):18-25. PubMed ID: 22120832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?
    Bouskila M; Pajvani UB; Scherer PE
    Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S17-23. PubMed ID: 15711577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of PPARgamma and PPARalpha agonists on serum leptin levels in diet-induced obese rats.
    Törüner F; Akbay E; Cakir N; Sancak B; Elbeg S; Taneri F; Aktürk M; Karakoç A; Ayvaz G; Arslan M
    Horm Metab Res; 2004 Apr; 36(4):226-30. PubMed ID: 15114521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
    Tsunoda M; Kobayashi N; Ide T; Utsumi M; Nagasawa M; Murakami K
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E833-40. PubMed ID: 18212024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes and SD rats.
    Lv Q; Wang Y; Wang W; Wang L; Zhou X
    Endocr Res; 2009; 34(4):130-41. PubMed ID: 19878073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.